Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Epilepsy
•
Neurology
•
Child Neurology
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
Related Questions
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
How does a patient’s BASED score after starting infantile spasms therapy guide your treatment plan?
What do you consider when clearing prophylactic anticoagulation in a pediatric patient with metastases in a dural venous sinus?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
How do you use aspirin in pre-symptomatic Sturge Weber patients?
What is your approach to dosing phenobarbital for a neonate on intermittent hemodialysis?
Besides patient preference, what factors guide your decision to treat SeLECTs patients with antiseizure medications?
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
